NASDAQ:MYGN

Myriad Genetics Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy MYGN

*Your capital is at risk

$4.40

+0.0900 (+2.09%)

At Close: Jun 03, 2026

Myriad Genetics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 89.65. In total, the insiders bought 4.96M and sold 277.39K MYGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	89.65
● Buy	4.96M shares
● Sell	277.39K shares
58% Buy Activity Moderate Negative Correlation
Buy Signal Medium Confidence Mar 12, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 89.65. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 24, 2025 Buy	Common Stock J-Other	Munk Natalie Officer	Officer	0 Value: $0
Sep 21, 2025 Sell	Common Stock F-InKind	Verratti Mark Chief Operating Officer	C-Suite Officer	1 085 Value: $8K
Sep 21, 2025 Sell	Common Stock F-InKind	Munk Natalie Chief Accounting Officer	Officer	962 Value: $7K
Sep 21, 2025 Sell	Common Stock F-InKind	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	2 559 Value: $19.9K
Sep 21, 2025 Sell	Common Stock F-InKind	Ancona Margaret EVP, Strategy & Transformation	Officer	958 Value: $7K
Sep 21, 2025 Sell	Common Stock F-InKind	Ancona Margaret EVP, Strategy & Transformation	Officer	958 Value: $7K
Sep 21, 2025 Sell	Common Stock F-InKind	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	2 559 Value: $19.9K
Sep 21, 2025 Sell	Common Stock F-InKind	Munk Natalie Chief Accounting Officer	Officer	962 Value: $7K
Sep 21, 2025 Sell	Common Stock F-InKind	Verratti Mark Chief Operating Officer	C-Suite Officer	1 085 Value: $8K
Sep 03, 2025 Sell	Common Stock F-InKind	Fox Jennifer Lynne Chief Legal Officer	Officer	4 435 Value: $30.2K
Sep 03, 2025 Sell	Common Stock F-InKind	Fox Jennifer Lynne Chief Legal Officer	Officer	4 435 Value: $30.2K
Aug 18, 2025 Buy	Common Stock J-Other	Leffler Scott J. Officer	Officer	0 Value: $0
Aug 18, 2025 Buy	Common Stock J-Other	Leffler Scott J. Officer	Officer	0 Value: $0
Aug 16, 2025 Buy	Common Stock A-Award	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	60 000 Value: $264.0K
Aug 16, 2025 Buy	Common Stock	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	0 Value: $0
Aug 16, 2025 Buy	Common Stock	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	0 Value: $0
Aug 16, 2025 Buy	Common Stock A-Award	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	60 000 Value: $264.0K
Jun 05, 2025 Buy	Common Stock A-Award	Dreismann Heinrich Director	Director	49 796 Value: $245.0K
Jun 05, 2025 Buy	Common Stock A-Award	Bisaro Paul Director	Director	49 796 Value: $245.0K
Jun 05, 2025 Buy	Common Stock A-Award	Davis Mark Steven Director	Director	24 148 Value: $118.8K
Jun 05, 2025 Buy	Common Stock A-Award	Phanstiel S. Louise Director	Director	49 796 Value: $245.0K
Jun 05, 2025 Buy	Common Stock A-Award	Newcomer Lee Nisley Director	Director	49 796 Value: $245.0K
Jun 05, 2025 Buy	Common Stock A-Award	Reitan Colleen F Director	Director	49 796 Value: $245.0K
Jun 05, 2025 Buy	Common Stock A-Award	Kumar Rashmi Director	Director	49 796 Value: $245.0K
Jun 05, 2025 Buy	Common Stock A-Award	Skovronsky Daniel Director	Director	49 796 Value: $245.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MYRIAD GENETICS

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing...

Read Full Profile Here